Citius Oncology
(NASDAQ) CTOR
Citius Oncology Financials at a Glance
Market Cap
$65.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$5.61M
Net Income (TTM)
-$42.51M
EPS (TTM)
-$0.47
P/E Ratio
-1.52
Dividend
$0.00
Beta (Volatility)
-1.71 (Low)
Dividend
$0.00
Beta (Volatility)
-1.71 (Low)
Price
$0.68
Volume
31,725
Open
$0.73
Price
$0.68
Volume
31,725
Open
$0.73
Previous Close
$0.71
Daily Range
$0.68 - $0.73
52-Week Range
$0.49 - $4.80
Estimated Earnings Date
Aug 18, 2026
Dividend
$0.00
Beta (Volatility)
-1.71 (Low)
Price
$0.68
Volume
31,725
Open
$0.73
Previous Close
$0.71
Daily Range
$0.68 - $0.73
52-Week Range
$0.49 - $4.80
Estimated Earnings Date
Aug 18, 2026
CTOR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Citius Oncology
Industry
Biotechnology
Sector
Health CareCEO
Leonard L. Mazur, MBA
Website
citiusonc.comHeadquarters
New York City, NY 10170, US
CTOR Financials
Key Financial Metrics (TTM)
Gross Margin
80.07%
Operating Margin
-775.60%
Net Income Margin
-757.57%
Return on Equity
-99.47%
Return on Capital
-48.33%
Return on Assets
-42.22%
Earnings Yield
-65.79%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$65.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
92.98M
Volume
31.73K
Avg. Volume
90.99K
Financials (TTM)
Gross Profit
$4.49M
Operating Income
-$43.52M
EBITDA
-$41.08M
Operating Cash Flow
-$16.86M
Capital Expenditure
-$14.00
Free Cash Flow
-$16.86M
Cash & ST Invst.
$2.63M
Total Debt
$3.80M
Citius Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.67M
N/A
Gross Profit
$1.34M
N/A
Gross Margin
80.27%
N/A
Market Cap
$65.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$231.28K
N/A
Employees
285
N/A
Net Income
-$26.61M
-244.0%
EBITDA
-$26.81M
-258.8%
Quarterly Fundamentals
Total Cash
$2.63M
+2350466.1%
Total Debt
$3.80M
+0.0%
Accounts Receivable
$1.08M
N/A
Inventory
$22.66M
+47.7%
Long Term Debt
$3.80M
+0.0%
Short Term Debt
$0.00
N/A
Return on Assets
-42.22%
N/A
Return on Invested Capital
-1.04%
N/A
Free Cash Flow
-$3.97M
N/A
Operating Cash Flow
-$3.97M
N/A